Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SE vs MRNA✓SelectedUSD · MRNASE vs MRNA performance historyLatest closeAs of-1.21%11/18
Stock and ETF performance explorer

SE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+466.9%
MRNA return
+794.5%
Excess return
-327.6%
Maximum drawdown
-90.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.2%-4.8%+3.6%-0.7%
7D-7.3%-20.9%+13.6%-4.9%
30D-22.5%-13.3%-9.2%-21.5%
3M-41.0%+212.6%-253.6%-53.5%
6M-22.3%+309.0%-331.3%-42.4%
YTD-46.2%+567.3%-613.5%-64.2%
1Y-53.4%+689.7%-743.1%-70.1%
3Y+82.6%+157.4%-74.9%+34.8%
5Y-77.9%-21.7%-56.2%-80.4%
All+466.9%+794.5%-327.6%+334.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling